Modern biotechnology is the lab-based application of scientific knowledge to biological organisms. Its main applications are in medical, agricultural food crops, industrial (non-food) crops, and environmental uses. It combines disciplines such as cell biology, genetics, molecular chemistry and biochemistry.
Business is the driving force behind biotechnological research and application. It has a responsibility to ensure that products meet current international standards and rules and to promote an appropriate, science-based regulatory environment.
Enhance confidence in biotechnology by fostering awareness of and appreciation of the societal benefits arising from technological innovation; seek to prevent non science-based barriers to trade in biotechnology products; advocate sound science and risk management as the basis of regulatory approaches to food safety and environmental stewardship.
Photo: National Science Foundation*
Richard A. Johnson
Arnold & Porter, LLP
Janet E. Collins
Global Biotechnology Manager
Director – Life Sciences and Product Policy
(212) 703-5047 or email@example.com
· Provide industry leadership on key OECD biotechnology policy and regulatory activities, including Consensus Documents for environmental risk assessment of transgenic crops; the Horizontal Innovation Strategy Project; and addressing intellectual property issues in the OECD accession process.
· Advocate to the U.S. Government and OECD for the need for future OECD work corresponding to human-health related biotechnology to be considered within a framework of innovation and economic growth.
· Promote biotechnology interests in international forums such as the UN Environment Program (UNEP) Governing Council/Global Ministerial Environment Forum and Aarhus Convention discussions.
· Met with US government officials to discuss the Aarhus Convention and the 2010 UNEP Governing Council meetings and its implications for US industry.
· Submitted comments on behalf of US industry on the OECD’s Low-Level Presence Project.
· Met with US delegate to the OECD Science Committee to advocate US business interests in OECD matters related to biotechnology and innovation.
· Coordinated with the ICC to ensure USCIB members have input into the Convention on Biological Diversity position papers and negotiations.
· Participated in an ICC delegation to Convention on Biological Diversity negotiations and met with the Executive Secretary to convey business positions.